ABSTRACT
BACKGROUND: Bradykinesia, tremor, rigidity and postural instability are the hallmark of Parkinson's disease (PD). Non-motor symptoms including cognitive, behavioral, and neuropsychiatric changes, sensory and sleep disturbances that may precede the motor symptoms by years. The peculiar pathological features of PD are decreased dopaminergic neurons and dopamine levels in the substantia nigra pars compacta and pontine locus coeruleus. Humanin is produced by a small gene peptide, which is located in the mitochondria genome. Inflammation, oxidative stress, mitochondrial dysfunction and altered transcription have been recognized as causative factors of PD. This evidence has prompted many researchers to focus on studying the functions of DNA and mitochondria. The purpose of the present study was to evaluate Humanin mRNA levels in peripheral blood mononuclear cells (PBMCs) of PD subjects, compared with those in PBMCs of normal control (NC) subjects. METHODS AND RESULTS: A total of 220 participants, including 154 PD patients (57 females and 97 males; mean age 71.54 years, SD 7.8) and 66 CN (28 females and 38 males; mean age 70.54 years, SD 9.45) were enrolled for the qRT-PCR analysis. Increased Humanin mRNA levels were found in PD samples, compared to controls. CONCLUSION: In conclusion, the present data confirm the tendency of mitochondria to overexpress mRNA in PD, which could be a cellular attempt to reduce apoptotic damage in PD subjects. Humanin might be useful as a marker for a better diagnosis of PD, and we cannot exclude that in the future it might also play a role on prognosis and in the possible therapies for PD.
Subject(s)
Parkinson Disease , Male , Female , Humans , Aged , Parkinson Disease/metabolism , Leukocytes, Mononuclear/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Gene Expression/geneticsABSTRACT
Down syndrome (DS) is characterized by trisomy of chromosome 21 and peculiar phenotype. Humanin (HN) is a mitochondrial short 24-residue polypeptide whit anti-apoptotic and neuroprotective effects. In this study we evaluated HN protein expression and HN mRNA levels in cultured fibroblasts from DS patients and normal controls. Our results obtained by immunocytochemistry, western-blot and qRT-PCR analysis show a significant HN up-regulation in DS patients. These results confirm previous studies and suggest a role for HN may in the DS phenotype.
Subject(s)
Down Syndrome/genetics , Down Syndrome/metabolism , Gene Expression/genetics , Apoptosis/genetics , Apoptosis/physiology , Blotting, Western , Fibroblasts/metabolism , Fluorescent Antibody Technique , Humans , Mitochondria/metabolism , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
BACKGROUND: Klinefelter syndrome (KS) is characterized by the presence of at least one supernumerary X chromosome. KS typical symptoms include tall stature, gynecomastia, hypogonadism and azoospermia. KS patients show a higher risk of developing metabolic and cardiovascular diseases, inflammatory and autoimmune disorders, osteoporosis and cancer. Long non-coding RNA (lncRNA) growth arrest-specific 5 (GAS5) has been shown to be involved in several biologic processes, including inflammatory and autoimmune diseases, vascular endothelial cells apoptosis and atherosclerosis, as well as cellular growth and proliferation, cellular development and cell-to-cell signaling and interaction. The lncRNA GAS5 expression profile in KS patients has never been evaluated so far. METHODS: To accomplish this, GAS5 mRNA levels were evaluated by Next Generation Sequencing (NGS) technology and qRT-PCR assay in 10 patients with KS and 10 age-matched controls. RESULTS: NGS results showed a significantly lncRNAGAS5up-regulation by 5.171-fold in patients with KS. Theresults of qRT-PCR confirmed the NGS data. CONCLUSIONS: These findings showed the occurrence of lncRNA GAS5 over-expression in KS patients. Whether this lncRNA is involved in the pathogenesis of inflammation and autoimmune diseases, atherogenesis or germ cell depletion in KS patients is not known. Further studies are needed.
Subject(s)
Gene Expression Regulation , Klinefelter Syndrome/genetics , RNA, Long Noncoding/biosynthesis , RNA, Long Noncoding/genetics , Up-Regulation , Adult , High-Throughput Nucleotide Sequencing , Humans , RNA, Messenger , Rare Diseases/genetics , Real-Time Polymerase Chain Reaction , Sequence Analysis, RNASubject(s)
Down Syndrome/genetics , Gene Expression , MicroRNAs/genetics , Adult , Animals , Chromosomes, Human, Pair 17/genetics , Chromosomes, Human, Pair 21/genetics , Female , Humans , Leukocytes/metabolism , Male , Mice , MicroRNAs/metabolism , Middle Aged , Neuronal Outgrowth/genetics , Neuronal Plasticity/genetics , Synaptic Transmission/geneticsABSTRACT
OBJECTIVE: Trisomy 21 is the most frequent genetic cause of intellectual disability. Tumor Protein 53 (TP53) gene down-regulation triggers chromosomal instability. A TP53 gene polymorphism c.215G > C (rs1042522) is associated with accumulation of aneuploid cells. We analyzed the TP53 c.215G > C (rs1042522) polymorphism in Sicilian mothers of subjects with Down Syndrome (DS) within a case-control study. METHODS: Nucleotide polymorphism was detected by pyrosequencing technology. RESULTS: The distribution of TP53 c.215G > C polymorphism showed significant difference between mothers of subjects with DS and controls. CONCLUSIONS: Our data show that TP53 c.215G > C polymorphism is a risk factor for DS in Sicilian mothers.
Subject(s)
Down Syndrome/genetics , Mothers , Polymorphism, Single Nucleotide , Tumor Suppressor Protein p53/genetics , Adult , Aged , Case-Control Studies , Down Syndrome/epidemiology , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Middle Aged , Pregnancy , Risk Factors , Sicily/epidemiologySubject(s)
Down Syndrome/genetics , NF-kappa B p50 Subunit/metabolism , Adult , Female , Gene Expression , Humans , Male , Middle AgedSubject(s)
Caspase 3/genetics , Gene Expression Regulation, Neoplastic/genetics , Gene Expression/genetics , Poly(ADP-ribose) Polymerases/genetics , Prostatic Neoplasms/genetics , Up-Regulation/genetics , Caspase 3/metabolism , Cell Line, Tumor , Humans , Male , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/metabolismABSTRACT
Down syndrome (DS) is a chromosomal disorder caused by chromosome 21 trisomy and is the most frequent genetic cause of intellectual disability. The gene for the kinesin family member 21A (KIF21A), is a member of the kinesin superfamily involved in the anterograde fast axonal transport. In this study, we have evaluated the possible differential expression of KIF21A mRNA, by qRT-PCR, in peripheral blood leukocytes of DS subjects and it compared with the normal population. In the assumption that changes in KIF21A gene expression levels may affect the axonal transport and the development of the nervous system of subjects with DS. In the present case-control study, KIF21A gene expression was increased in 72.72 % of DS samples compared with normal subjects. This finding suggests that changes in the expression levels of KIF21A in DS subjects may affect the axonal transport and the development of the nervous system.
